Cudetaxestat

DB18203InvestigationalSmall molecule

Cudetaxestat: Overview.

Chemical structure of Cudetaxestat
Formula / weight
C21H15Cl2F2N3O2S · 482.33 g/mol (avg)
Also known as
3-((2,6-dichloro-7-fluoro-1-(1-propyl-1h-pyrazol-4-yl)-1h-indol-3-yl)thio)-2-fluorobenzoic acid · Benzoic acid, 3-((2,6-dichloro-7-fluoro-1-(1-propyl-1h-pyrazol-4-yl)-1h-indol-3-yl)thio)-2-fluoro-
Code names
BLD-0409 · PAT-409

Resolves to

Compound
UNII6B7TYB2MJXCAS1782070-21-6ChEMBLCHEMBL4802146
Structure
InChIKeyNMDFAQXLJQRHMS-UHFFFAOYSA-NSMILESCCCN1C=C(C=N1)N1C(Cl)=C(SC2=CC=CC(C(O)=O)=C2F)C2=CC=C(Cl)C(F)=C12
Targets
Q13822ENPP2

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Cudetaxestat, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In